How to create value with constrained budgets in oncological care? A narrative review
Open Access
- 1 September 2023
- journal article
- review article
- Published by Taylor & Francis in Expert Review of Pharmacoeconomics & Outcomes Research
- Vol. 23 (9) , 989-999
Abstract
As a result of an increasing focus on patient-centered care within oncology and more pressure on the sustainability of health-care systems, the discussion on what exactly constitutes value re-appears. Policymakers seek to improve patient values; however, funding all values is not sustainable. We collect available evidence from scientific literature and reflect on the concept of value, the possible incorporation of a wide spectrum of values in reimbursement decisions, and alternative strategies to increase value in oncological care. We state that value holds many different aspects. For reimbursement decisions, we argue that it is simply not feasible to incorporate all patient values because of the need for efficient resource allocation. We argue that we should shift the value debate from the individual perspective of patients to creating value for the cancer population at large. The different strategies we address are as follows: (1) shared decision-making; (2) biomarkers and molecular diagnostics; (3) appropriate evaluation, payment and use of drugs; (4) supportive care; (5) cancer prevention and screening; (6) monitoring late effect; (7) concentration of care and oncological networking; and (8) management of comorbidities. Important preconditions to support these strategies are strategic planning, consistent cancer policies and data availability.Keywords
This publication has 76 references indexed in Scilit:
- Efficacy of a Regional Network for Ovarian Cancer CareObstetrics & Gynecology, 2013
- International Variability in the Reimbursement of Cancer Drugs by Publically Funded Drug ProgramsCurrent Oncology, 2012
- Effects of multidisciplinary team working on breast cancer survival: retrospective, comparative, interventional cohort study of 13 722 womenBMJ, 2012
- How Cancer Patients Value Hope And The Implications For Cost-Effectiveness Assessments Of High-Cost Cancer TherapiesHealth Affairs, 2012
- Person-Centered Care — Ready for Prime TimeEuropean Journal of Cardiovascular Nursing, 2011
- Delivering affordable cancer care in high-income countriesThe Lancet Oncology, 2011
- Health outcomes in economic evaluation: the QALY and utilitiesBritish Medical Bulletin, 2010
- Health Care Costs in the Last Week of LifeArchives of internal medicine (1960), 2009
- KRAS mutations predict response to EGFR inhibitorsCurrent Opinion in Pharmacology, 2008
- The challenge of complexity in health careBMJ, 2001